Investors

Genomic Vision is a publicly-traded company on the Euronext regulated market in Paris

Corporate Presentation

Regulated Information

General Assembly

Stock Information

Medias

Video

> Labiotech.eu – DNA Molecular Combing: A new paradigm in the detection of genetic diseases with Charles Caulliez, Director of Corporate Business Development at Genomic Vision / July 2017

> Le Revenu – Interview of Stephane Altaba, VP Corporate Development of Genomic Vision following the technological collaboration signed with AstraZeneca in oncology / May 23^rd, 2017

> Interview of Aaron Bensimon during the Company’s Investor Day / March 23^rd, 2016

In the press

24/07/2019

Business trends – A step forward in HPV diagnostics

27/04/2017

Biotech & Finances – Interview audio d’Aaron Bensimon

29/01/2017

La Bourse et la Vie – Interview d’Aaron Bensimon

10/01/2017

Le Revenu – Genomic Vision : début d’année en fanfare

15/06/2016

La Tribune – Genomic Vision veut devenir un contrôleur qualité de l’édition du génome

frise

genomic_web_visuels_footer_COMPANY